The Innovator's Dilemma by Clayton Christensen
The study of management pathology remains young. While we can (usually) tell when a company has died, our identification of the cause of death comes across as no better than "major organs stopped working" ( 1] customers up and left, 2] gov't closed firm). With balanced scorecards, we are beginning to collect objective monitoring data on companies, however, as physicians, we have not yet created a community repository of patient histories.
Maybe we have killer babies on the loose, maybe we don't. Say you're a small nation and you want to make killer babies. How do you know you're actually making killer babies? Say you succeed, do you now have other problems?
Despite the failings, I still enjoyed reading this book as it afforded plenty of opportunity to view the material from different perspectives. E.g., everywhere he says "successful company", "customers", and "small, innovative company"; replace that with "you", "your employer", and "your replacement", respectively. The book (unintentionally) has plenty to mull over.
Companies stumble for many reasons, of course
- Companies depend on customers and investors for resources
- Small markets don't solve the growth needs of larger companies
- Markets that don't exist can't be analyzed
- Technology supply may not equal market demand